Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Bio-Nems
AddedFeb 18, 2024
UpdatedJun 18, 2026
Bio-Nems

Bio-Nems

Angel

SnapDNA/BIO-NEMS: A biotech firm innovating for safer, fresher food through cost-effective safety tools.

HQ
Broomfield, CO, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

Bio-Nems, also known as SnapDNA/BIO-NEMS, is a biotechnology company dedicated to enhancing food safety. Founded with the mission to reduce the number and severity of foodborne outbreaks, the company aims to lower production costs and ensure fresher, safer food. Bio-Nems offers innovative tools and technologies designed specifically for food safety professionals, addressing critical needs in the food production and processing industry.

Notable figures affiliated with Bio-Nems include key investors and industry experts who support the company's mission. The firm has achieved significant milestones in developing cost-effective safety tools that have positively impacted food safety standards. Through its cutting-edge solutions, Bio-Nems has contributed to reducing foodborne illnesses and improving overall public health, establishing itself as a pivotal player in the biotech sector focused on food safety.

Bio-Nems - Similar Companies

BioDatomics logo

BioDatomics

biodatomics.com

NemaLife logo

NemaLife

nemalifeinc.com

Canomiks logo

Canomiks

canomiks.com

NouBio logo

NouBio

noubio.co

Biota Technology logo

Biota Technology

biota.com

Zymeron logo

Zymeron

zymeron.com

Innova Nutra logo

Innova Nutra

Secure Food Solutions logo

Secure Food Solutions

BioNanovations logo

BioNanovations

Biotia logo

Biotia

biotia.io

Foodsafetypcr logo

Foodsafetypcr

Twist Bioscience logo

Twist Bioscience

Aanika Biosciences logo

Aanika Biosciences

aanikabio.com

InSyBio logo

InSyBio

insybio.gr

Granata Bio logo

Granata Bio

granata.bio

Bio-Nems - Quick Facts

Who are Bio-Nems' competitors?

Companies similar to Bio-Nems include BioDatomics, NemaLife, Canomiks and NouBio.

When was Bio-Nems founded?

Bio-Nems was founded in 2011.

Where is Bio-Nems' headquarters located?

Bio-Nems' headquarters is located in Broomfield, CO, US.

When was Bio-Nems' last funding round?

Bio-Nems' most recent funding round was for $250k (USD) in November 2021.

How much has Bio-Nems raised to-date?

As of Nov 18, 2021, Bio-Nems has raised a total of $1.2M (USD).

How many employees does Bio-Nems have?

Bio-Nems has 7 employees as of Feb 4, 2024.

Bio-Nems - Classification

Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Food Safety
Tags
  • Data
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software